13 years of trabectedin, 5 years of Yondelis®: what have we learnt?
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
http://www.tandfonline.com/doi/pdf/10.1586/era.13.49
Reference29 articles.
1. Efficacy and Safety of Trabectedin in Patients With Advanced or Metastatic Liposarcoma or Leiomyosarcoma After Failure of Prior Anthracyclines and Ifosfamide: Results of a Randomized Phase II Study of Two Different Schedules
2. Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas
3. Mapping the literature: Role of trabectedin as a new chemotherapy option in advanced pretreated soft tissue sarcoma
4. Phase II Study of ET-743 in Advanced Soft Tissue Sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group Trial
5. Phase II Study of Ecteinascidin-743 in Advanced Pretreated Soft Tissue Sarcoma Patients
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Single-Center Experience with Trabectedin for the Treatment of Non-L-sarcomas;Advances in Therapy;2022-02-07
2. Marine-Derived Anticancer Agents: Clinical Benefits, Innovative Mechanisms, and New Targets;Marine Drugs;2019-06-02
3. Pummerer-Type Reactions as Powerful Tools in Organic Synthesis;Molecular Rearrangements in Organic Synthesis;2015-10-02
4. Trabectedin clinical cases: use according to indication in diverse clinical scenarios;Future Oncology;2015-06
5. Optimizing the use of trabectedin for advanced soft tissue sarcoma in daily clinical practice;Future Oncology;2015-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3